Benzinga | Sep 30, 2020 05:58AM EDT

Wells Fargo Downgrades Ironwood Pharmaceuticals to Equal-Weight, Announces $9 Price Target

Wells Fargo analyst Jacob Hughes downgrades Ironwood Pharmaceuticals (NASDAQ:IRWD) from Overweight to Equal-Weight and announces $9 price target.